Literature DB >> 1500859

Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.

S D Voss1, P M Sondel, R J Robb.   

Abstract

Interleukin 2 (IL-2) receptors expressed on the surface of activated T cells and natural killer (NK) cells exhibit a variety of affinity states depending on their subunit composition. Low-affinity binding is associated with a 55-kDa alpha chain, intermediate-affinity binding with a 70-75-kD beta chain, and high-affinity binding with a bimolecular complex of the alpha and beta subunits. In a previous study of the IL-2 receptors expressed on NK cells obtained from cancer patients after in vivo IL-2 therapy, we documented a discrepancy between the level of beta chain and the level of intermediate-affinity IL-2 binding sites expressed on the cell surface. Based on this result, we postulated that formation of intermediate-affinity receptor sites required a component in addition to the beta chain, and that this component was present at limiting levels in the patient NK cells. In the present study we have examined the structure of the intermediate-affinity receptor complex using monoclonal antibodies that recognize the beta chain, but that do not interfere with its ability to bind IL-2. Evidence is presented establishing the physical association of a novel protein of 64 kD with the beta chain in intermediate-affinity IL-2 binding sites. This molecule, termed IL-2R gamma chain, coprecipitated with beta chains prepared from cells that had been incubated with IL-2, but was undetectable in immunoprecipitates prepared in the absence of IL-2. Examination of gamma chain expression in post-IL-2 therapy NK cells, where only low levels of intermediate-affinity IL-2 binding were detectable, revealed that the gamma chain was associated with, on average, only 10-12% of the beta chains expressed on such cells. This contrasted with approximately equal levels of beta and gamma chain expression on YT cells, a cell line that has both high levels of cell surface beta chain expression and high levels of IL-2 binding. Thus, the ratio of gamma chain to beta chain present in the immunoprecipitates roughly correlated with the proportion of beta chain involved in intermediate-affinity receptor sites. This result suggests that the 64-kD gamma chain is the component responsible for regulating the affinity of IL-2 association with the beta subunit. By further defining the structural components necessary for IL-2 receptor formation, these studies provide additional insight into mechanisms whereby lymphocytes might regulate their responsiveness to IL-2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500859      PMCID: PMC2119323          DOI: 10.1084/jem.176.2.531

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  49 in total

1.  Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells.

Authors:  P Anderson; M Caligiuri; C O'Brien; T Manley; J Ritz; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).

Authors:  J Yodoi; K Teshigawara; T Nikaido; K Fukui; T Noma; T Honjo; M Takigawa; M Sasaki; N Minato; M Tsudo
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  The beta-chain of the IL-2 receptor (p70) is tyrosine-phosphorylated on YT and HUT-102B2 cells.

Authors:  M Sharon; J R Gnarra; W J Leonard
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

4.  Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies.

Authors:  M Tsudo; F Kitamura; M Miyasaka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Characterization of the heterodimeric complex of human IL-2 receptor alpha.beta chains reconstituted in a mouse fibroblast cell line, L929.

Authors:  S Minamoto; H Mori; M Hatakeyama; T Kono; T Doi; T Ide; T Uede; T Taniguchi
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

6.  A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.

Authors:  M Hatakeyama; H Mori; T Doi; T Taniguchi
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

7.  Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated.

Authors:  G B Mills; C May; M McGill; M Fung; M Baker; R Sutherland; W C Greene
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

8.  IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody.

Authors:  J Suzuki; T Takeshita; K Ohbo; H Asao; K Tada; K Sugamura
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

9.  Partial agonist/antagonist mouse interleukin-2 proteins indicate that a third component of the receptor complex functions in signal transduction.

Authors:  S M Zurawski; J L Imler; G Zurawski
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

Authors:  T Takeshita; Y Goto; K Tada; K Nagata; H Asao; K Sugamura
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  34 in total

Review 1.  The immune system in the elderly: III. Innate immunity.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; D Quaglino
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines.

Authors:  Zulmarie Perez Horta; Swetha Saseedhar; Alexander L Rakhmilevich; Lakeesha Carmichael; Jacquelyn A Hank; Margaret Boyden; Stephen D Gillies; Paul M Sondel
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

3.  Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Authors:  Blanca E Ruiz-Medina; Jeremy A Ross; Robert A Kirken
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

4.  Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.

Authors:  William H D Hallett; Erik Ames; Maite Álvarez; Isabel Barao; Patricia A Taylor; Bruce R Blazar; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

Review 5.  The interaction of intestinal epithelial cells and intraepithelial lymphocytes in host defense.

Authors:  Y Yoshikai
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation.

Authors:  Yajun Wang; Chawon Yun; Beixue Gao; Yuanming Xu; Yana Zhang; Yiming Wang; Qingfei Kong; Fang Zhao; Chyung-Ru Wang; Sharon Y R Dent; Jian Wang; Xiangping Xu; Hua-Bin Li; Deyu Fang
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

7.  Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.

Authors:  S D Voss; T P Leary; P M Sondel; R J Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Interleukin-15 may be responsible for early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats.

Authors:  K Hirose; H Suzuki; H Nishimura; A Mitani; J Washizu; T Matsuguchi; Y Yoshikai
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapy.

Authors:  C Soubrane; R Mouawad; M Ichen; J Suissa; C Borel; E Vuillemin; A Benhammouda; J P Bizzari; M Weil; D Khayat
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

10.  The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface.

Authors:  J C Mulloy; R W Crownley; J Fullen; W J Leonard; G Franchini
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.